Datta T, Bauchinger M, Emmerich B, Reichle A
GSF-Forschungszentrum für Umwelt und Gesundheit, Institut für Strahlenbiologie, München-Neuherberg, F.R.G.
Cancer Genet Cytogenet. 1991 Aug;55(1):49-56. doi: 10.1016/0165-4608(91)90234-l.
Chromosome analyses were performed by routine G-banding in 29 patients with B-cell chronic lymphocytic leukemia (B-CLL), six with immunocytoma (IC), three with centroblastic-centrocytic (cb-cc) lymphoma, and one with hairy cell leukemia (HCL). Ages of the patients were between 46 and 81 years (mean, 63 years). 12-O-tetradecanoyl-phorbol-13-acetate (TPA) was used as a mitogen to stimulate leukemic B-cells in 72-hour cultures. Twenty-one patients had one or more chromosomal abnormalities; and in 13 patients, they were clonal; 18 patients had a normal karyotype. Seven patients had trisomy 12 (three B-CLL, two IC, two cb-cc lymphoma); two (B-CLL) had it as the sole abnormality. One patient with B-CLL had trisomy 18 as the sole abnormality, and one with IC had trisomy 18 in combination with trisomy 19. One patient with B-CLL had t(1;6)(p36;p21) as a clonal structural abnormality. A t(11;14)(q13;q32) was consistently observed in one patient with cb-cc lymphoma together with inv(1) (p22p36), der(4)t(4;?)(p16;?), del(6)(q13) and other variable changes. One patient with morphologically atypical B-CLL had t(1;11)(p36;q13) together with der(X)t(X;?)(q26;?), der(3)t(3;?)(q29;?), der(8)t(4;8)(q12;q24.1) and additional variable changes. Both patients with these complex karyotypes were in an advanced stage of disease (Binet stage C) and died within 3-6 months after chromosome analysis.
对29例B细胞慢性淋巴细胞白血病(B - CLL)患者、6例免疫细胞瘤(IC)患者、3例中心母细胞 - 中心细胞(cb - cc)淋巴瘤患者和1例毛细胞白血病(HCL)患者进行了常规G显带染色体分析。患者年龄在46至81岁之间(平均63岁)。使用12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)作为有丝分裂原,在72小时培养中刺激白血病B细胞。21例患者有一个或多个染色体异常;13例患者的异常是克隆性的;18例患者核型正常。7例患者有12号染色体三体(3例B - CLL、2例IC、2例cb - cc淋巴瘤);2例(B - CLL)以此为唯一异常。1例B - CLL患者以18号染色体三体为唯一异常,1例IC患者有18号染色体三体合并19号染色体三体。1例B - CLL患者有t(1;6)(p36;p21)作为克隆性结构异常。在1例cb - cc淋巴瘤患者中始终观察到t(11;14)(q13;q32),同时伴有inv(1)(p22p36)、der(4)t(4;?)(p16;?)、del(6)(q13)和其他可变变化。1例形态学非典型B - CLL患者有t(1;11)(p36;q13),同时伴有der(X)t(X;?)(q26;?)、der(3)t(3;?)(q29;?)、der(8)t(4;8)(q12;q24.1)和其他可变变化。这两名具有复杂核型的患者均处于疾病晚期(Binet分期C期),并在染色体分析后3至6个月内死亡。